Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review.
about
Efficacy of memantine, donepezil, or their association in moderate-severe Alzheimer's disease: a review of clinical trialsA fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's diseaseThe Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.Use of anti-dementia drugs in home care and residential care and associations with neuropsychiatric symptoms: a cross-sectional studyDisease-modifying drugs in Alzheimer's disease.Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia.EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.Memantine extended release (28 mg once daily): a review of its use in Alzheimer's disease.Dementia: A complex disease with multiple etiologies and multiple treatments.The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes.Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease.Management of Behavioral and Psychological Symptoms of Dementia.Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysisNeuroprotective effects of donepezil against Aβ42-induced neuronal toxicity are mediated through not only enhancing PP2A activity but also regulating GSK-3β and nAChRs activity.(E)-2-Methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) Phenol Ameliorates LPS-Mediated Memory Impairment by Inhibition of STAT3 Pathway.Combined treatment with memantine/es-citalopram for older depressed patients with cognitive impairment: a pilot study.Cognitive and neuropsychiatric impairments in Alzheimer's disease: current treatment strategies.Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review
P2860
Q26851862-A8B9F5AC-5E8C-4623-AEA7-90A0BA73DAC0Q28076715-801E4D57-1E36-4E34-8963-ADB03957F16BQ33165801-5A42DFAF-0531-401F-9FC2-01AE13D87FD4Q35744523-64DB58F6-DA6F-40DC-8132-7BC7D88715EFQ37390739-849E65C4-E20D-4B6B-8EC3-C9AD83D536BEQ38099671-4665D476-C593-415A-B9AB-0EC6EE394BAEQ38350602-451B06C4-5037-4A63-A74B-0E044B7C68B8Q38391086-565658E3-3FDB-4A48-B596-FFEDB43F92C0Q38433924-C08D1F10-BC18-4676-ABC6-CEE602990B1CQ38760122-FCF00A50-0202-44D6-AFED-86A461929D6CQ38775856-ED745FC8-FD8D-470A-BCF6-E6109DA923DEQ38906350-E1DBD219-384D-4E4B-9DD2-AA275CBE35DFQ39209888-C3E1A92D-C566-46E7-BAA3-7FE9BBAC6841Q41474879-8173368E-8236-478D-B6DC-5A39B7C6EC0AQ46669273-DC4B3802-1718-4BEF-993B-2D1CD3A9D5FAQ46925056-27D327D8-D187-43F1-8480-B7770778651FQ48070645-2F785098-7635-46F7-B6ED-5DF00966774DQ48254545-4911DB02-FFA2-44C2-95F8-6FD660746D4AQ53377510-97F47121-7358-44FD-B375-5D780BD4E9DFQ58698874-15F5819D-4AAC-48C0-AF49-98EAE08EC745
P2860
Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Memantine and cholinesterase i ...... disease: a systematic review.
@ast
Memantine and cholinesterase i ...... disease: a systematic review.
@en
type
label
Memantine and cholinesterase i ...... disease: a systematic review.
@ast
Memantine and cholinesterase i ...... disease: a systematic review.
@en
prefLabel
Memantine and cholinesterase i ...... disease: a systematic review.
@ast
Memantine and cholinesterase i ...... disease: a systematic review.
@en
P2860
P1433
P1476
Memantine and cholinesterase i ...... disease: a systematic review.
@en
P2093
Lucy E Farrimond
Rupert McShane
P2860
P356
10.1136/BMJOPEN-2012-000917
P577
2012-06-11T00:00:00Z